Real‐world characteristics and outcomes of patients with multiple myeloma receiving second‐line treatment in England

Abstract Introduction Despite recent advances in first‐line therapies for multiple myeloma (MM), most patients relapse or become refractory, underscoring the need for effective second‐line (2L) regimens for relapsed/refractory MM (RRMM). Methods This study describes the real‐world baseline character...

Full description

Saved in:
Bibliographic Details
Main Authors: Sally Moore, Laura Cornic, Christina‐Jane Crossman‐Barnes, Sophie Jose, Zeyad Khalaf, Kwee Yong, Megan Soutar, Philip Woods
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:eJHaem
Subjects:
Online Access:https://doi.org/10.1002/jha2.1058
Tags: Add Tag
No Tags, Be the first to tag this record!